Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,945 | 464 | 97.4% |
| Education | $210.61 | 8 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,377 | 52 | $0 (2021) |
| PFIZER INC. | $970.77 | 51 | $0 (2021) |
| Novo Nordisk Inc | $816.32 | 61 | $0 (2021) |
| GlaxoSmithKline, LLC. | $759.79 | 35 | $0 (2021) |
| Lilly USA, LLC | $601.40 | 28 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $592.00 | 39 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $561.71 | 48 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $430.30 | 33 | $0 (2019) |
| Amgen Inc. | $231.98 | 10 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $217.38 | 18 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $12.89 | 1 | Astellas Pharma US Inc ($12.89) |
| 2021 | $580.29 | 27 | Biohaven Pharmaceuticals, Inc. ($102.02) |
| 2020 | $267.62 | 18 | PFIZER INC. ($51.09) |
| 2019 | $2,189 | 127 | AstraZeneca Pharmaceuticals LP ($381.40) |
| 2018 | $1,883 | 132 | AstraZeneca Pharmaceuticals LP ($265.43) |
| 2017 | $3,223 | 167 | AstraZeneca Pharmaceuticals LP ($701.81) |
All Payment Transactions
472 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/04/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Urology | ||||||
| 10/06/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: RESPIRATORY | ||||||
| 08/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: UROLOGY | ||||||
| 07/22/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Neuroscience | ||||||
| 07/14/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRIJARDY XR | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: DIABETES | ||||||
| 06/24/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: DIABETES | ||||||
| 06/23/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Obesity | ||||||
| 06/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: NEUROSCIENCE | ||||||
| 06/02/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Diabetes | ||||||
| 05/27/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: WOMENS HEALTH | ||||||
| 05/20/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: UROLOGY | ||||||
| 05/19/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Obesity | ||||||
| 05/13/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: DIABETES | ||||||
| 05/06/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes | ||||||
| 05/04/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/08/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: NEUROSCIENCE | ||||||
| 04/01/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: DIABETES | ||||||
| 03/25/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Diabetes | ||||||
| 03/18/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $18.71 | General |
| Category: Neurology | ||||||
| 03/10/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $63.07 | General |
| Category: RESPIRATORY | ||||||
| 03/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/03/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $19.80 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 152 | 170 | $34,006 | $8,812 |
| 2021 | 13 | 506 | 696 | $80,510 | $40,464 |
| 2020 | 9 | 477 | 681 | $83,872 | $32,358 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 88 | $20,400 | $5,238 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 82 | $13,606 | $3,574 | 26.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 162 | 285 | $48,450 | $23,592 | 48.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 86 | 131 | $15,065 | $7,241 | 48.1% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 13 | 13 | $3,250 | $3,104 | 95.5% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 26 | 26 | $1,820 | $1,727 | 94.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 81 | 81 | $3,240 | $1,425 | 44.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 11 | 28 | $2,800 | $836.19 | 29.9% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 22 | 22 | $770.00 | $607.82 | 78.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 16 | $1,920 | $561.54 | 29.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 33 | 33 | $990.00 | $519.75 | 52.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 19 | 19 | $570.00 | $299.19 | 52.5% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 18 | 18 | $630.00 | $283.50 | 45.0% |
| 90471 | Administration of 1 vaccine | Office | 2021 | 11 | 13 | $455.00 | $166.14 | 36.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 11 | 11 | $550.00 | $100.35 | 18.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 177 | 293 | $49,810 | $18,193 | 36.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 131 | 199 | $22,885 | $8,768 | 38.3% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 41 | 41 | $2,870 | $2,501 | 87.1% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 17 | 24 | $2,880 | $927.30 | 32.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 51 | 52 | $1,575 | $817.34 | 51.9% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 12 | 23 | $2,300 | $684.79 | 29.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 16 | 17 | $510.00 | $265.86 | 52.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 14 | 14 | $700.00 | $140.71 | 20.1% |
| 81002 | Urinalysis, manual test | Office | 2020 | 18 | 18 | $342.00 | $58.88 | 17.2% |
About Dr. Scott Lieberman, MD
Dr. Scott Lieberman, MD is a Internal Medicine healthcare provider based in Franklin, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1871644781.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Lieberman, MD has received a total of $8,155 in payments from pharmaceutical and medical device companies, with $12.89 received in 2022. These payments were reported across 472 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($7,945).
As a Medicare-enrolled provider, Lieberman has provided services to 1,135 Medicare beneficiaries, totaling 1,547 services with total Medicare billing of $81,633. Data is available for 3 years (2020–2022), covering 24 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Franklin, TN
- Active Since 01/16/2007
- Last Updated 01/08/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871644781
Products in Payments
- FARXIGA (Drug) $542.34
- TRELEGY ELLIPTA (Drug) $451.66
- SYMBICORT (Drug) $441.00
- JANUVIA (Drug) $360.87
- TRULICITY (Drug) $327.70
- Victoza (Drug) $292.34
- JARDIANCE (Drug) $286.99
- XARELTO (Drug) $281.79
- LYRICA (Drug) $280.98
- CHANTIX (Drug) $279.30
- EUCRISA (Drug) $263.69
- BEVESPI AEROSPHERE (Drug) $251.78
- Ozempic (Drug) $250.99
- TRADJENTA (Drug) $190.01
- Uloric (Drug) $181.83
- Saxenda (Drug) $167.65
- ELIQUIS (Drug) $152.77
- INVOKANA (Drug) $148.51
- Livalo (Drug) $144.22
- XIFAXAN (Drug) $137.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Franklin
Devin Sherman, Md, MD
Internal Medicine — Payments: $144,092
Dr. George Cornett, M.d, M.D
Internal Medicine — Payments: $82,680
Gaston Dana, Do, DO
Internal Medicine — Payments: $20,633
Michael Barr, M.d., M.b.a, M.D., M.B.A
Internal Medicine — Payments: $12,767
Dr. Jean Tan, Md, MD
Internal Medicine — Payments: $12,376
James Mcginley, Md, MD
Internal Medicine — Payments: $11,766